Are ACOs Ready to be Accountable for Medication Use?
Autor: | Greg Kotzbauer, Kimberly Westrich, Scott D. Pope, Marv Feldman, Jerry Penso, Adam Lustig, Robert W. Dubois |
---|---|
Rok vydání: | 2020 |
Předmět: |
Cost-Benefit Analysis
media_common.quotation_subject MEDLINE Pharmaceutical Science Pharmacy Drug Costs 03 medical and health sciences 0302 clinical medicine Cost Savings Humans Medicine Operations management Quality (business) 030212 general & internal medicine Disease management (health) Quality Indicators Health Care media_common Medication use Accountable Care Organizations Delivery of Health Care Integrated business.industry 030503 health policy & services Health Policy Insurance Pharmaceutical Services Quality Improvement Benchmarking Cross-Sectional Studies Incentive Health Care Surveys Accountable care 0305 other medical science business |
Zdroj: | Journal of Managed Care & Specialty Pharmacy. 26:1446-1451 |
ISSN: | 2376-1032 2376-0540 |
Popis: | BACKGROUND: Accountable care organizations (ACOs) have the potential to lower costs and improve quality through incentives and coordinated care. However, the design brings with it many new challenges. One such challenge is the optimal use of pharmaceuticals. Most ACOs have not yet focused on this integral facet of care, even though medications are a critical component to achieving the lower costs and improved quality that are anticipated with this new model. OBJECTIVE: To evaluate whether ACOs are prepared to maximize the value of medications for achieving quality benchmarks and cost offsets. METHODS: During the fall of 2012, an electronic readiness self-assessment was developed using a portion of the questions and question methodology from the National Survey of Accountable Care Organizations, along with original questions developed by the authors. The assessment was tested and subsequently revised based on feedback from pilot testing with 5 ACO representatives. The revised assessment was distributed via... |
Databáze: | OpenAIRE |
Externí odkaz: |